Aspire BioPharma is trading 5.5% up today at $7.43, rebounding after yesterday’s profit-taking pullback.
- The move aligns with a broader biotech rally and firm overall market sentiment lifting riskier growth and speculative names.
- There is no fresh company-specific news or catalyst reported today to drive the price action.